Article
Pharmacokinetic and pharmacogenetic analysis of oral busulfan in stem cell transplantation: prediction of poor drug metabolism to prevent drug toxicity.
Current drug safety - 1 Jul 2012
Krivoy Norberto, Zuckerman Tsila, Elkin Hela, Froymovich Lia, Rowe Jacob M, Efrati Edna
Abstract excerpt
High dose busulfan (BU) has become a mainstay in conditioning regimens for hematopoietic stem cell transplantation (HSCT), despite its unpredictable response, narrow therapeutic index and severe toxicity. The present study provides an integration of pharmacokinetic and genetic data of 63 adults w...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
